Contact this trialFirst, we need to learn more about you.
Vancomycin for Clostridium Difficile Infection
Recruiting0 awardsPhase 2
Rochester, Minnesota
This trial is testing whether oral vancomycin can help prevent recurrent Clostridium difficile Infection (CDI) in patients who have had at least one CDI episode in the past 180 days and are taking antibiotics for a non-CDI condition.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.